OKYO
OKYO
NASDAQ · Biotechnology

Okyo Pharma Ltd

$1.92
+0.02 (+1.05%)
As of Feb 8, 2:15 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,404.7% upside
Low Target $16.92
Average Target $28.89
High Target $30.86
Current Price $1.92
Current
$1.92
Target
$28.89
$16.92 $28.89 avg $30.86
Scenario Analysis
Bear Case
$16.92
781.3%
Low target
Base Case
$28.89
+1,404.7%
Avg target
Bull Case
$30.86
+1,507.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$30.12
-93.6% from high
52-Week Low
$19.11
+-90.0% from low
Target vs 52W High
$28.89
-4.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%